Durand, Christelle M. http://orcid.org/0000-0002-3890-0632
Angelini, Chloé
Michaud, Vincent
Delleci, Claire
Coupry, Isabelle
Goizet, Cyril
Trimouille, Aurelien
Funding for this research was provided by:
Association Strumpell Lorrain
Sanofi Genzyme
Fondation maladies rares
Enroll HD
Article History
Received: 29 October 2021
Accepted: 9 January 2022
First Online: 12 February 2022
Declarations
:
: Written informed consent was received from the patient according to the declaration of Helsinki principles of medical research involving human subjects. Experiments were approved by the Comité de Protection des Personnes Bordeaux Outre-Mer III.
: Written informed consent for publication was received from the patient.
: Dr. Durand received research support from the Association Strumpell-Lorrain (ASL).Pr Goizet received consulting fees from Overlord, honoraria for lectures from Sanofi Genzyme, Biomarin, Amicus, Biogen, financial support for research activities from Genzyme, Association Strumpell-Lorrain (ASL), Enroll HD, and inscriptions and travels for congresses were funded by Sanofi Genzyme, Amicus and Akcea.Dr. Trimouille received research support from the Fondation Maladies Rares (FMR).C Angelini, Dr. Michaud, Dr. Dellci and Dr. Coupry report no disclosures.